Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
26 hedge funds and large institutions have $9M invested in Orgenesis Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 16 reducing their positions, and 8 closing their positions.
1.54% less ownership
Funds ownership: 8.95% → 7.42% (-1.5%)
19% less capital invested
Capital invested by funds: $11.1M → $9M (-$2.11M)
21% less funds holding
Funds holding: 33 → 26 (-7)
52% less call options, than puts
Call options by funds: $187K | Put options by funds: $387K
81% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 16
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$169K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$30.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.8K |
| 4 |
Barclays
London,
United Kingdom
|
+$1.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$544K |
| 2 |
SG Americas Securities
New York
|
-$324K |
| 3 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$324K |
| 4 |
JP Morgan Chase
New York
|
-$227K |
| 5 |
Renaissance Technologies
New York
|
-$185K |
ORGS Hedge Fund Activity: Q3 2021 in Review
26 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q3 2021, worth a combined $9M — down 19% from $11.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ORGS and 1 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 3 added.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $169K. The largest seller was Millennium Management, cutting an estimated $544K.
- 26 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q3 2021, down from 33 in Q2 2021.
- Funds reported $9M of Orgenesis Inc. Common Stock stock for Q3 2021, down 19% quarter-over-quarter.
- 1 fund opened new Orgenesis Inc. Common Stock positions in Q3 2021 and 8 closed out, a net change of -7 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q3 2021 was D.E. Shaw & Co, an estimated $169K added.
- The largest Orgenesis Inc. Common Stock seller in Q3 2021 was Millennium Management, an estimated $544K sold.
Based on aggregated 13F filings for Q3 2021.